Japan News
-
Metoject subcutaneous injection pen launches in Japan for rheumatic arthritis treatment
Japan | News | 0 Comment | 22 May, 2024
Eisai Co. and nippon medac Co., a subsidiary of medac group, have launched the anti-rheumatic agent 'Metoject Subcutaneo...Read more
-
Astellas partners with Yaskawa to create innovative cell therapy ecosystem in Japan
Japan | News | 1 Comment | 21 May, 2024
Astellas Pharma Inc. has signed a Memorandum of Understanding (MoU) with Yaskawa Electric Corporation to begin discussio...Read more
-
Japan | News | 0 Comment | 20 May, 2024
Could you elaborate on some of the most prominent trends shaping the landscape of clinical trials in the Asia-Pacific re...Read more
-
Japan's HOYA Group to distribute AI-assisted lesion detection device in US
Japan | News | 0 Comment | 18 May, 2024
HOYA Group Company, PENTAX of America, Inc. (PENTAX Medical, a division of HOYA Group) and MAGENTIQ-EYE , an artif...Read more
-
AC Immune and Takeda Pharma ink $2.1 B deal for immunotherapy to delay Alzheimer's progression
Japan | News | 0 Comment | 15 May, 2024
Japan-headquartered pharmaceutical firm Takeda and Swiss firm AC Immune SA have announced an exclusive, worldwide o...Read more
-
Japan's Shionogi announces $150 M deal to develop first oral therapy for Pompe Disease
Japan | News | 0 Comment | 13 May, 2024
Japan-based Shionogi & Co. and Maze Therapeutics, Inc., in the US, have completed an exclusive worldwide license agr...Read more
-
Japan's GHIT invests $10.8 M to develop new drugs for malaria & NTDs
Japan | News | 0 Comment | 09 May, 2024
The Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.64 bill...Read more
-
Japan Kidney Association and Renalys Pharma form collaborative agreement to overcome kidney disease
Japan | News | 0 Comment | 10 May, 2024
The Japan Kidney Association, a nonprofit organisation, and Renalys Pharma, Inc., have entered into a collaborat...Read more
-
Takara Bio launches first commercial dissolvable microfluidic lentiviral transduction enhancer
Japan | News | 0 Comment | 07 May, 2024
Takara Bio USA, Inc., a wholly owned subsidiary of Japan-headquartered Takara Bio Inc., has announced the launch of the ...Read more
-
Japan approves AI-powered surgical visualisation tool Eureka α
Japan | News | 0 Comment | 03 May, 2024
Anaut Inc., a pioneering developer in surgical support software led by Dr Nao Kobayashi, has announced the regulato...Read more
-
Japan-based PeptiDream inks $2.71 B deal with Novartis
Japan | News | 0 Comment | 02 May, 2024
Japan-based PeptiDream Inc has announced an expansion of its peptide discovery collaboration with Swiss-based firm&...Read more
-
US based C₂N Diagnostics expands Alzheimer’s diagnostics into Japan
Japan | News | 0 Comment | 30 Apr, 2024
C₂N Diagnostics, a specialty diagnostics company with a vision to bring Clarity Through Innovation, has announced a pa...Read more
-
Japan's Yokogawa helps to revolutionise Single-Cell Lipidomics
Japan | News | 0 Comment | 29 Apr, 2024
Japanese multinational company Yokogawa Electric Corporation’s latest single-cell analysis solution, the Single Ce...Read more
-
デュポンは STARLIMS を使用して 研究開発ラボでの試験を統合しました
Japan | News | 0 Comment | 11 Apr, 2024
200 年を超える歴史があるデュポンは、常に先頭に立って化学分野における革新的なイノ...Read more
-
Japanese Foundation for Cancer Research collaborates with Takeda Pharma
Japan | News | 0 Comment | 24 Apr, 2024
Japanese Foundation for Cancer Research (JFCR) and Takeda Pharmaceutical have signed a partnership agreement with the go...Read more
-
Takeda, Astellas and Sumitomo to establish JV for drug discovery programmes in Japan
Japan | News | 0 Comment | 23 Apr, 2024
Takeda Pharmaceutical, Astellas Pharma and Sumitomo Mitsui Banking Corporation (SMBC), in Japan, have signed a master ag...Read more
-
Japan | News | 0 Comment | 22 Apr, 2024
Japan-headquartered Shimadzu Corporation and Tohoku University have opened the Shimadzu × Tohoku University Supers...Read more
-
Eisai's antiepileptic drug Fycompa injection formulation launches in Japan
Japan | News | 0 Comment | 18 Apr, 2024
Eisai Co. has announced that the injection formulation of its in-house discovered antiepileptic drug (AED) Fycompa (pera...Read more
